Multimodal genomic markers predict immunotherapy response in the head and neck squamous cell carcinoma
Gaurav Kumar, Andrew P. South, Joseph Curry…·Adam Luginbuhl
The paper evaluates existing ICB biomarkers and identifies a novel signature to predict immunotherapy response in HNSCC using TCGA and clinical trial data.